
|
Replicon enters into a two-year business development partnership
15-12-2003, ph
PRESS RELEASE (December 15, 2003)
Replicon Corporate Finance Ltd has entered into a long-term partnership to accelerate the business development and global distribution of innovative diagnostic concepts.
Replicon Corporate Finance Ltd announced today a two-year strategic relationship with Finnish diagnostic company to accelerate the business development and international expansion of the company's innovative diagnostic concepts. The outsourcing agreement will automatically continue for two additional years, if certain conditions are met.
The outsourcing agreement for financial and legal expertise, as well as part of the business development includes the build out of a global distribution network combined with certain business intelligence services as well as cooperation in developing concepts for next generation products. The agreement will focus specifically on the growing demand for new and innovative diagnostic solutions and the management of international expansion through distributors. Through its relationship with Replicon, the company plans to provide it's product on a global basis. Replicon's financial and legal services will help the company's operations to increase value of their intellectual property by optimizing contractual relationships between distributors and other business partners.
`With this agreement, the company is taking a leadership position in delivering new and advanced diagnostic solutions that allows clients in their pursuit of cost savings and increased productivity� said Petteri Hirvonen, CEO, Replicon Group. `By expanding the relationship with Replicon, the company is better positioned to utilize distribution channels to deliver new solutions to the market quickly and with minimized legal and financial risks.�
`Replicon's goal is to provide the company with complete financial and legal cababilities, saving them time and resources to focus on their core business and operations� said Jari Lauriala, Partner at Replicon Corporate Finance. `Our focused services on expansion management and certain core operations, helps the company become more competitive.�
For further information, please contact:
Replicon Corporate Finance Oy
Petteri Hirvonen, CEO
+358 (09)677 464
petteri.hirvonen@replicon.fi
Replicon Group provides strategic, financial, and legal solutions that facilitate business activities, efficiency, and increase profitability of corporations and other organizations. Our core competence is in the corporate solutions that facilitate and govern growth of businesses based on innovation. An important part of our activities is continuous learning. We want to find and develop most suitable solutions to our customer needs. Replicon Group's special focus areas are Life-Science and ICT -sectors The main shareholders in Replicon Corporate Finance Oy are its key management, holding majority of the company's shares. Replicon's homepage is www.replicon.fi
|
Recent articles:
> 19-08-2010 - Valuation Services and Total Life Cycle Cost Analyses > 04-05-2010 - Oversol Oy / Lumi Group Oy Raises First Part of 2-4 M€ Financing > 22-03-2010 - Replicon Continues as Certified Adviser in NASDAQ OMX First North > 22-03-2010 - Replicon Group jatkaa NASDAQ OMX:ssä neuvonantajana > 22-01-2010 - Replicon Initiates Multimillion Financing Project for Promising LED Application > 06-10-2009 - Replicon Newsletter Q3/2009 > 09-09-2009 - New Certification for Replicon Group > 24-08-2009 - Replicon toimittaa asiantuntija-palvelupaketin Qentinel Oy:lle > 17-08-2009 - ASIAVIIHDE: videoidut talouskirja-arvostelut > 16-06-2009 - Replicon Group Company Awarded 2 Year R&D Project > 21-05-2009 - Replicon Newsletter Q2/2009 > 21-05-2009 - Repliconin Uutiskirje Q2/2009 > 03-02-2009 - Replicon Newsletter Q1/2009 > 19-01-2009 - Jouko Ahvenainen Presenting in Mobile World Congress in Barcelona > 19-12-2008 - Replicon Creates an Option Arrangement for Its Client > 29-10-2008 - Results from Client Survey > 18-09-2008 - Tuottavuus ja rahoitus 2008 -seminaari > 17-06-2008 - Ani Biotech buys the Business Operations of Orgenium Laboratories > 20-05-2008 - Tietoisku FIRST NORTH -markkinapaikasta > 31-03-2008 - Replicon Collaboration Partner Forms Global Multi-Centre Network > 30-01-2008 - Replicon helps EVE to Receive Private Equity Financing > 29-01-2008 - Replicon Pharma Portfolio Outperforms Benchmark Index Fifth Year in a Row > 29-11-2007 - Replicon Group OMX First Northin Certified Adviseriksi > 29-11-2007 - Replicon Group becomes Certified Adviser in OMX First North > 28-11-2007 - Matti Copeland Repliconin neuvonantajaksi > 15-10-2007 - Replicon Private Equity -tapahtuma > 24-09-2007 - Talentor Receives Private Equity Financing Package in Record Time > 07-08-2007 - Meet Replicon in Autumn 2007 > 11-05-2007 - Replicon and Imanext Form Strategic Collaboration > 17-04-2007 - Pääjohtaja Liikanen puhumassa Repliconin Tuottavuus -seminaarissa > 17-04-2007 - BoF Governor Speaking at Replicon Productivity Seminar > 09-03-2007 - Top Seminar: ICT Companies as Productivity Boosters > 08-03-2007 - Xtract raises € 2 million in venture capital funding from Eqvitec > 21-02-2007 - ICT-yritykset tuottavuuden nostajina - Repliconin Tuottavuus ja rahoitus -seminaari 17.4.2007 > 29-01-2007 - Replicon MDF Portfolio Outperforms Benchmark Index Fourth Year in a Row > 29-01-2007 - Repliconin Pharma portfolio (MDF) ylittänyt jälleen vertailuindeksin tuoton > 08-01-2007 - Replicon toimittaa asiantuntijapalvelupaketin Qentinel Oy:lle > 15-12-2006 - Replicon Provides Expert Services for Xtract, Ltd. > 01-11-2006 - Replicon Provides Compensation Arrangement Planning for Growth Companies > 01-11-2006 - Replicon toteuttaa osakesidonnaisia kannustinjärjestelmiä kasvuyrityksille > 26-10-2006 - Petteri Hirvonen Presenting in Global UMTS TDD Alliance Summit in London > 28-09-2006 - Jouko Ahvenainen Presenting in Mobile Marketing Service Summit in Lisbon > 29-05-2006 - First Half Management Consulting Projects of Replicon > 01-04-2006 - Replicon Launches Investigational Asset Management Portfolio in ICT sector > 02-03-2006 - Enfucell Receives First VC Round of Financing > 20-02-2006 - Replicon Helps Arranging Significant Financing Package for a Client > 29-01-2006 - Replicon Portfolio Outperforms Benchmark Third Year in a Row > 02-01-2006 - Replicon Hires Satu Vapaakallio as Analyst > 24-11-2005 - Replicon Initiate 7.5Meur Private Placement Process for SkyWeb Oy > 14-10-2005 - CTT Cancer Targeting Technologies Ltd enters into R&D agreement with GE Healthcare > 05-09-2005 - Orgenium receives financing from Abroad and Expands Production to Low Cost Production Site in Ankara, Turkey > 20-07-2005 - Replicon helps arranging financing for #CMAX.gg > 31-03-2005 - Replicon in BioFinland 05 Investor Forum > 29-01-2005 - Replicon Biotech Value Portfolio Outperforms NASDAQ Biotech Index Second Year in a Row > 26-01-2005 - Replicon Extends Its Life Science Expert Team > 18-01-2005 - All Replicon Senior Partners Gain Accreditation by the Ministry of Trade and Industry > 10-01-2005 - Jouko Ahvenainen (MBA, M.Sc.) joins Replicon as a Senior Partner > 17-12-2004 - Replicon to Develop a Model for Enhancing Commercialization of Bone Research in Finland > 29-10-2004 - Replicon moves to WTC Helsinki > 15-10-2004 - MBA Petri Laulajainen joins Replicon as a Senior Partner > 02-07-2004 - Orgenium closes financing round with private investors and Finnish Industry Investment Ltd. > 27-05-2004 - Replicon's new strategic partners announced > 07-04-2004 - Viope closes financing round for expansion > 29-01-2004 - Replicon Biotech Model Portfolio Annual Return 78 per cent > 15-12-2003 - Replicon enters into a two-year business development partnership > 19-08-2003 - Dr. Hannu Silvennoinen joins as a Senior Partner > 09-04-2003 - Replicon forms corporate finance unit > 28-01-2003 - Replicon Launches Model Portfolio in Biotech
|
|